Brenda Wong
About
Brenda Wong is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Genetics.
According to data from OpenAlex, Brenda Wong has authored 142 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 109 papers in Molecular Biology, 26 papers in Cardiology and Cardiovascular Medicine and 25 papers in Genetics. Recurrent topics in Brenda Wong's work include Muscle Physiology and Disorders (87 papers), Neurogenetic and Muscular Disorders Research (23 papers) and Cardiomyopathy and Myosin Studies (18 papers). Brenda Wong is often cited by papers focused on Muscle Physiology and Disorders (87 papers), Neurogenetic and Muscular Disorders Research (23 papers) and Cardiomyopathy and Myosin Studies (18 papers). Brenda Wong collaborates with scholars based in United States, United Kingdom and France. Brenda Wong's co-authors include Paul S. Horn, Linda Cripe, Richard S. Finkel, Mary Schroth, John G. Quinlan, Ching H. Wang, Anita K. Simonds, Thomas O. Crawford, Leslie Morrison and Anthony Trela and has published in prestigious journals such as PLoS ONE, Neurology and PEDIATRICS.
In The Last Decade
Brenda Wong
138 papers receiving 4.1k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Brenda Wong United States | 36 | 2.9k | 1.1k | 914 | 714 | 558 | 142 | 4.2k | ||
| Sonia Messina Italy | 37 | 3.0k 1.0× | 1.5k 1.4× | 628 0.7× | 866 1.2× | 531 1.0× | 114 | 4.3k | ||
| Nathalie Goemans Belgium | 33 | 3.9k 1.4× | 1.1k 1.0× | 932 1.0× | 493 0.7× | 496 0.9× | 136 | 5.0k | ||
| Adele D’Amico Italy | 36 | 3.0k 1.0× | 1.3k 1.1× | 661 0.7× | 682 1.0× | 544 1.0× | 168 | 4.2k | ||
| Marika Pane Italy | 36 | 2.5k 0.9× | 1.6k 1.4× | 587 0.6× | 894 1.3× | 290 0.5× | 127 | 3.9k | ||
| Julaine Florence United States | 36 | 2.9k 1.0× | 1.4k 1.2× | 562 0.6× | 528 0.7× | 783 1.4× | 66 | 5.0k | ||
| Michela Guglieri United Kingdom | 31 | 2.8k 1.0× | 813 0.7× | 623 0.7× | 219 0.3× | 447 0.8× | 104 | 3.5k | ||
| Thomas Voït Germany | 40 | 3.5k 1.2× | 982 0.9× | 1.1k 1.2× | 411 0.6× | 1.0k 1.9× | 136 | 5.3k | ||
| Massimiliano Mirabella Italy | 41 | 2.8k 1.0× | 665 0.6× | 764 0.8× | 433 0.6× | 468 0.8× | 166 | 5.4k | ||
| Anneke J. van der Kooi Netherlands | 45 | 3.2k 1.1× | 1.3k 1.2× | 1.4k 1.5× | 610 0.9× | 688 1.2× | 151 | 6.4k | ||
| Susan T. Iannaccone United States | 45 | 4.0k 1.4× | 2.9k 2.6× | 1.3k 1.4× | 1.6k 2.2× | 617 1.1× | 159 | 6.9k |
Countries citing papers authored by Brenda Wong
Since
Specialization
Citations
This map shows the geographic impact of Brenda Wong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brenda Wong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brenda Wong more than expected).
Fields of papers citing papers by Brenda Wong
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Brenda Wong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brenda Wong. The network helps show where Brenda Wong may publish in the future.
Co-authorship network of co-authors of Brenda Wong
This figure shows the co-authorship network connecting the top 25 collaborators of Brenda Wong. A scholar is included among the top collaborators of Brenda Wong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brenda Wong. Brenda Wong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Muntoni, Francesco, James Signorovitch, Gautam Sajeev, et al.. (2024). Meaningful changes in motor function in Duchenne muscular dystrophy (DMD): A multi-center study. PLoS ONE. 19(7). e0304984–e0304984.
2.
Holzhausen, Elizabeth A., William B. Patterson, Brenda Wong, et al.. (2024). Associations between human milk EV-miRNAs and oligosaccharide concentrations in human milk. Frontiers in Immunology. 15. 1463463–1463463.
3.
Muntoni, Francesco, James Signorovitch, Gautam Sajeev, et al.. (2022). Real-world and natural history data for drug evaluation in Duchenne muscular dystrophy: suitability of the North Star Ambulatory Assessment for comparisons with external controls. Neuromuscular Disorders. 32(4). 271–283.
4.
Tian, Cuixia, et al.. (2021). The effect of oral bisphosphonate therapy on vertebral morphometry and fractures in patients with Duchenne muscular dystrophy and glucocorticoid‐induced osteoporosis. Muscle & Nerve. 64(6). 710–716.
5.
Marden, Jessica R., et al.. (2020). Real-world outcomes of long-term prednisone and deflazacort use in patients with Duchenne muscular dystrophy: experience at a single, large care center. Journal of Comparative Effectiveness Research. 9(3). 177–189.
6.
Reyngoudt, Harmen, Benjamin Marty, Pierre‐Yves Baudin, et al.. (2019). Abstracts from “Imaging in Neuromuscular Disease 2019: Second International Conference on Imaging in Neuromuscular Disease, 17th – 19th November 2019 | Berlin, Germany”. Journal of Neuromuscular Diseases. 6(s2). S1–S62.
7.
Horn, Paul S., et al.. (2017). Genotype-phenotype associations in a large cohort of Duchenne muscular dystrophy patients. Neuromuscular Disorders. 27. S104–S105.
8.
Campbell, Craig, Perry B. Shieh, Thomas Sejersen, et al.. (2016). Safety and Tolerability of Ataluren in a Phase 3 Study of Patients with Nonsense Mutation Duchenne Muscular Dystrophy (P3.164). Neurology. 86(16_supplement).
9.
Hendriksen, Jos G.M., et al.. (2016). Diagnosis and treatment of obsessive compulsive behavior in a boy with Duchenne muscular dystrophy and autism spectrum disorder: A case report. Neuromuscular Disorders. 26(10). 659–661.
10.
Tandon, Animesh, John L. Jefferies, Chet Villa, et al.. (2015). Dystrophin Genotype–Cardiac Phenotype Correlations in Duchenne and Becker Muscular Dystrophies Using Cardiac Magnetic Resonance Imaging. The American Journal of Cardiology. 115(7). 967–971.
11.
Tandon, Animesh, Chet Villa, Kan N. Hor, et al.. (2015). Myocardial Fibrosis Burden Predicts Left Ventricular Ejection Fraction and Is Associated With Age and Steroid Treatment Duration in Duchenne Muscular Dystrophy. Journal of the American Heart Association. 4(4).
12.
Liu, Da Zhi, Boryana Stamova, Bradley P. Ander, et al.. (2015). MicroRNA and mRNA Expression Changes in Steroid Naïve and Steroid Treated DMD Patients. Journal of Neuromuscular Diseases. 2(4). 387–396.
13.
Wong, Brenda, Boryana Stamova, P. Morehart, et al.. (2015). microRNA and mRNA expression networks in Duchenne muscular dystrophy. Neuromuscular Disorders. 25. S253–S254.
14.
Wong, Brenda, Lauren E. Miller, Paul S. Horn, et al.. (2013). P.11.6 Functional motor changes in Duchenne Muscular Dystrophy (DMD) patients on long term daily glucocorticoid (GC) treatment. Neuromuscular Disorders. 23(9-10). 800–800.
15.
Pardo, Andrea C., et al.. (2011). Combination of steroids and ischial weight-bearing knee ankle foot orthoses in Duchenne’s muscular dystrophy prolongs ambulation past 20 years of age – A case report. Neuromuscular Disorders. 21(11). 800–802.
16.
Kalra, Maninder, et al.. (2009). Survival Probabilities of Patients With Childhood Spinal Muscle Atrophy. Journal of Clinical Neuromuscular Disease. 10(3). 85–89.
17.
Henderson, Richard C., Lisa Berglund, Ryan May, et al.. (2009). The relationship between fractures and DXA measures of BMD in the distal femur of children and adolescents with cerebral palsy or muscular dystrophy. Journal of Bone and Mineral Research. 25(3). 520–526.
18.
Walker, Wynn L., Donald L. Gilbert, Brenda Wong, et al.. (2008). Empirical Bayes accomodation of batch-effects in microarray data using identical replicate reference samples: application to RNA expression profiling of blood from Duchenne muscular dystrophy patients. BMC Genomics. 9(1). 494–494.
19.
Reha, A., Gary Elfring, Richard S. Finkel, et al.. (2008). T.P.5.01 Phase 2b Study of PTC124 in Duchenne/Becker muscular dystrophy (DMD/BMD): Demographic and other baseline data. Neuromuscular Disorders. 18(9-10). 823–823.
20.
Finkel, Richard S., Brenda Wong, Kevin M. Flanigan, et al.. (2007). G.P.3.05 Phase 2 study of PTC124 for nonsense mutation suppression therapy of Duchenne muscular dystrophy (DMD). Neuromuscular Disorders. 17(9-10). 783–783.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Sonia Messina Breakdown of academic impact, for papers by Nathalie Goemans Breakdown of academic impact, for papers by Adele D’Amico Breakdown of academic impact, for papers by Marika Pane Breakdown of academic impact, for papers by Julaine Florence Breakdown of academic impact, for papers by Michela Guglieri Breakdown of academic impact, for papers by Thomas Voït Breakdown of academic impact, for papers by Massimiliano Mirabella Breakdown of academic impact, for papers by Anneke J. van der Kooi Breakdown of academic impact, for papers by Susan T. Iannaccone